Industry: Chemical & Material
Published Date: 2026-04-18
Pages: 127 Pages
Report ld: 6482689
Request Sample
Customized Report
The global Lasmiditan Succinate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Lasmiditan Succinate competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Lamiditan succinate, also known as lamitetan perate, is an oral prescription drug for the acute treatment of migraine in adults with or without aura.
The North American market for Lasmiditan Succinate is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Lasmiditan Succinate is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Lasmiditan Succinate include Molnova, Excenen Pharmatech, Hubei Gedian Humanwell Pharma, Nantong HI-FUTURE Biology, ShiJiaZhuang Chirals Chemical, Shenzhen Shengda Pharma Limited, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Lasmiditan Succinate market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Lasmiditan Succinate. The Lasmiditan Succinate market size, estimates, and forecasts are provided in terms of output/shipments (Kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Lasmiditan Succinate market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Lasmiditan Succinate manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Lasmiditan Succinate manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Lasmiditan Succinate production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Lasmiditan Succinate consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Lasmiditan Succinate Market Overview
1.1 Product Definition
1.2 Lasmiditan Succinate by Type
1.2.1 Global Lasmiditan Succinate Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Purity ≥98%
1.2.3 Purity ≥99%
1.3 Lasmiditan Succinate by Application
1.3.1 Global Lasmiditan Succinate Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Tablet
1.3.3 Oral Liquid
1.4 Global Market Growth Prospects
1.4.1 Global Lasmiditan Succinate Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Lasmiditan Succinate Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Lasmiditan Succinate Production Estimates and Forecasts (2021–2032)
1.4.4 Global Lasmiditan Succinate Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Lasmiditan Succinate Production Market Share by Manufacturers (2021–2026)
2.2 Global Lasmiditan Succinate Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Lasmiditan Succinate, Industry Ranking, 2024 vs 2025
2.4 Global Lasmiditan Succinate Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Lasmiditan Succinate Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Lasmiditan Succinate, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Lasmiditan Succinate, Product Offerings and Applications
2.8 Global Key Manufacturers of Lasmiditan Succinate, Date of Entry into the Industry
2.9 Lasmiditan Succinate Market Competitive Situation and Trends
2.9.1 Lasmiditan Succinate Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Lasmiditan Succinate Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Lasmiditan Succinate Production by Region
3.1 Global Lasmiditan Succinate Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Lasmiditan Succinate Production Value by Region (2021–2032)
3.2.1 Global Lasmiditan Succinate Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Lasmiditan Succinate by Region (2027–2032)
3.3 Global Lasmiditan Succinate Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Lasmiditan Succinate Production Volume by Region (2021–2032)
3.4.1 Global Lasmiditan Succinate Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Lasmiditan Succinate by Region (2027–2032)
3.5 Global Lasmiditan Succinate Market Price Analysis by Region (2021–2032)
3.6 Global Lasmiditan Succinate Production, Value, and Year-over-Year Growth
3.6.1 North America Lasmiditan Succinate Production Value Estimates and Forecasts (2021–2032)
3.6.2 China Lasmiditan Succinate Production Value Estimates and Forecasts (2021–2032)
3.6.3 Japan Lasmiditan Succinate Production Value Estimates and Forecasts (2021–2032)
4 Lasmiditan Succinate Consumption by Region
4.1 Global Lasmiditan Succinate Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Lasmiditan Succinate Consumption by Region (2021–2032)
4.2.1 Global Lasmiditan Succinate Consumption by Region (2021–2026)
4.2.2 Global Lasmiditan Succinate Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Lasmiditan Succinate Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Lasmiditan Succinate Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Lasmiditan Succinate Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Lasmiditan Succinate Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Lasmiditan Succinate Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Lasmiditan Succinate Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Lasmiditan Succinate Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Lasmiditan Succinate Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Lasmiditan Succinate Production by Type (2021–2032)
5.1.1 Global Lasmiditan Succinate Production by Type (2021–2026)
5.1.2 Global Lasmiditan Succinate Production by Type (2027–2032)
5.1.3 Global Lasmiditan Succinate Production Market Share by Type (2021–2032)
5.2 Global Lasmiditan Succinate Production Value by Type (2021–2032)
5.2.1 Global Lasmiditan Succinate Production Value by Type (2021–2026)
5.2.2 Global Lasmiditan Succinate Production Value by Type (2027–2032)
5.2.3 Global Lasmiditan Succinate Production Value Market Share by Type (2021–2032)
5.3 Global Lasmiditan Succinate Price by Type (2021–2032)
6 Segment by Application
6.1 Global Lasmiditan Succinate Production by Application (2021–2032)
6.1.1 Global Lasmiditan Succinate Production by Application (2021–2026)
6.1.2 Global Lasmiditan Succinate Production by Application (2027–2032)
6.1.3 Global Lasmiditan Succinate Production Market Share by Application (2021–2032)
6.2 Global Lasmiditan Succinate Production Value by Application (2021–2032)
6.2.1 Global Lasmiditan Succinate Production Value by Application (2021–2026)
6.2.2 Global Lasmiditan Succinate Production Value by Application (2027–2032)
6.2.3 Global Lasmiditan Succinate Production Value Market Share by Application (2021–2032)
6.3 Global Lasmiditan Succinate Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Molnova
7.1.1 Molnova Lasmiditan Succinate Company Information
7.1.2 Molnova Lasmiditan Succinate Product Portfolio
7.1.3 Molnova Lasmiditan Succinate Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Molnova Main Business and Markets Served
7.1.5 Molnova Recent Developments/Updates
7.2 Excenen Pharmatech
7.2.1 Excenen Pharmatech Lasmiditan Succinate Company Information
7.2.2 Excenen Pharmatech Lasmiditan Succinate Product Portfolio
7.2.3 Excenen Pharmatech Lasmiditan Succinate Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Excenen Pharmatech Main Business and Markets Served
7.2.5 Excenen Pharmatech Recent Developments/Updates
7.3 Hubei Gedian Humanwell Pharma
7.3.1 Hubei Gedian Humanwell Pharma Lasmiditan Succinate Company Information
7.3.2 Hubei Gedian Humanwell Pharma Lasmiditan Succinate Product Portfolio
7.3.3 Hubei Gedian Humanwell Pharma Lasmiditan Succinate Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Hubei Gedian Humanwell Pharma Main Business and Markets Served
7.3.5 Hubei Gedian Humanwell Pharma Recent Developments/Updates
7.4 Nantong HI-FUTURE Biology
7.4.1 Nantong HI-FUTURE Biology Lasmiditan Succinate Company Information
7.4.2 Nantong HI-FUTURE Biology Lasmiditan Succinate Product Portfolio
7.4.3 Nantong HI-FUTURE Biology Lasmiditan Succinate Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Nantong HI-FUTURE Biology Main Business and Markets Served
7.4.5 Nantong HI-FUTURE Biology Recent Developments/Updates
7.5 ShiJiaZhuang Chirals Chemical
7.5.1 ShiJiaZhuang Chirals Chemical Lasmiditan Succinate Company Information
7.5.2 ShiJiaZhuang Chirals Chemical Lasmiditan Succinate Product Portfolio
7.5.3 ShiJiaZhuang Chirals Chemical Lasmiditan Succinate Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 ShiJiaZhuang Chirals Chemical Main Business and Markets Served
7.5.5 ShiJiaZhuang Chirals Chemical Recent Developments/Updates
7.6 Shenzhen Shengda Pharma Limited
7.6.1 Shenzhen Shengda Pharma Limited Lasmiditan Succinate Company Information
7.6.2 Shenzhen Shengda Pharma Limited Lasmiditan Succinate Product Portfolio
7.6.3 Shenzhen Shengda Pharma Limited Lasmiditan Succinate Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Shenzhen Shengda Pharma Limited Main Business and Markets Served
7.6.5 Shenzhen Shengda Pharma Limited Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Lasmiditan Succinate Industry Chain Analysis
8.2 Lasmiditan Succinate Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Lasmiditan Succinate Production Modes and Processes
8.4 Lasmiditan Succinate Sales and Marketing
8.4.1 Lasmiditan Succinate Sales Channels
8.4.2 Lasmiditan Succinate Distributors
8.5 Lasmiditan Succinate Customer Analysis
9 Lasmiditan Succinate Market Dynamics
9.1 Lasmiditan Succinate Industry Trends
9.2 Lasmiditan Succinate Market Drivers
9.3 Lasmiditan Succinate Market Challenges
9.4 Lasmiditan Succinate Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Lasmiditan Succinate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 126
USD 3950.00
(Single User License)
The global Lasmiditan Succinate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-10
Pages: 80
USD 4250.00
(Single User License)
The global Lasmiditan Succinate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-08
Pages: 137
USD 4900.00
(Single User License)
The global market for Lasmiditan Succinate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 93
USD 3950.00
(Single User License)
The global market for Lasmiditan Succinate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 93
USD 2900.00
(Single User License)
Lamiditan succinate, also known as lamitetan perate, is an oral prescription drug for the acute treatment of migraine in adults with or without aura.
Published Date: 2024-04-15
Pages: 90
USD 4900.00
(Single User License)
Lamiditan succinate, also known as lamitetan perate, is an oral prescription drug for the acute treatment of migraine in adults with or without aura.
Published Date: 2024-01-17
Pages: 92
USD 2900.00
(Single User License)
The global market for Lasmiditan Succinate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 126
The global Lasmiditan Succinate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-10
Pages: 80
The global Lasmiditan Succinate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-08
Pages: 137
The global market for Lasmiditan Succinate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 93
The global market for Lasmiditan Succinate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 93
Lamiditan succinate, also known as lamitetan perate, is an oral prescription drug for the acute treatment of migraine in adults with or without aura.
Published: 2024-04-15
Pages: 90
Lamiditan succinate, also known as lamitetan perate, is an oral prescription drug for the acute treatment of migraine in adults with or without aura.
Published: 2024-01-17
Pages: 92
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now